Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications.

Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications. Abstract Text:

    jennifer x qiaoJennifer X Qiao,tammy c wangTammy C Wang,gren z wangGren Z Wang,daniel l cheneyDaniel L Cheney,kan heKan He,alan r rendinaAlan R Rendina,baomin xinBaomin Xin,joseph m luettgenJoseph M Luettgen,robert m knabbRobert M Knabb,ruth r wexlerRuth R Wexler,patrick y s lamPatrick Y S Lam,jennifer x qiaoJennifer X Qiao,tammy c wangTammy C Wang,gren z wangGren Z Wang,daniel l cheneyDaniel L Cheney,kan heKan He,alan r rendinaAlan R Rendina,baomin xinBaomin Xin,joseph m luettgenJoseph M Luettgen,robert m knabbRobert M Knabb,ruth r wexlerRuth R Wexler,patrick y s lamPatrick Y S Lam,

    We previously reported a series of enantiopure cis-(1R,2S)-cyclopentyldiamine derivatives as potent and selective inhibitors of Factor Xa (FXa). Herein, we describe our approach to improve the metabolic stability of this series via core modifications. Multiple resulting series of compounds demonstrated similarly high FXa potency and improved metabolic stability in human liver microsomes compared with the cyclopentyldiamide 1. (3R,4S)-Pyrrolidinyldiamide 31 was the best overall compound with human FXa K(i) of 0.50 nM, PT EC(2x) of 2.1 microM in human plasma, bioavailability of 25% and t(1/2)of 2.7h in dogs. Further biochemical characterization of compound 31 is also presented.

    Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications. Publishing Authors By Initials

    jx qiaoJX Qiao,tc wangTC Wang,gz wangGZ Wang,dl cheneyDL Cheney,k heK He,ar rendinaAR Rendina,b xinB Xin,jm luettgenJM Luettgen,rm knabbRM Knabb,rr wexlerRR Wexler,py lamPY Lam,jx qiaoJX Qiao,tc wangTC Wang,gz wangGZ Wang,dl cheneyDL Cheney,k heK He,ar rendinaAR Rendina,b xinB Xin,jm luettgenJM Luettgen,rm knabbRM Knabb,rr wexlerRR Wexler,py lamPY Lam,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Bioorganic & medicinal chemistry letters

    VOLUME: 17

    Page Numbers: 5041-8

    Journal Abbreviation: Bioorg. Med. Chem. Lett.

    ISSN: 0960-894X

    DAY: 13

    MONTH: 07

    YEAR: 2007

    Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9107377

    Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa. Improving in vitro metabolic stability via core modifications.

    AFFILIATION: Bristol-Myers Squibb Company, Research and Development, PO Box 5400, Princeton, NJ 08643-5400, USA. jennifer.qiao@bms.com

    Country: England

    England Research PublicationEngland Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Bioorg Med Chem Lett

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Enantiopure five-membered cyclicdiamine derivatives as potent and selective inhibitors of factor Xa Improving in vitro metabolic stability via core modifications Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News